Skip to content

To know the efficacy of Mahakukkuta Mamsa Taila Matra Basti ( medicine administered through anal route )in the management of Vataja Gridhrasi and comparing its effect with Moorchita Tila Taila Matra Basti ( medicine administered through anal route)

A Randomized Controlled Clinical Study To Evaluate Mahakukkutamamsa Taila Matra Basti In Vataja Gridhrasi - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075296
Enrollment
40
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

Dr Harshitha N Y
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria. Patients between the age group of 18-70 years of either sex. Patients who are fit for Matra Basti Karma. Patients who are willing to participate in the study and sign in the consent form.

Exclusion criteria

Exclusion criteria: Congenital Spinal Anomalies , surgical interventions of Lumbar spine. Patients with the symptoms of Vata Kaphaja Gridhrasi

Design outcomes

Primary

MeasureTime frame
To assess the following parameters Ruk (pain) Stamba (stiffness) Toda ( pricking sensation) Spandana (Pulsating and throbbing sensation)Timepoint: 1.5 years

Secondary

MeasureTime frame
To reduce any of these Ruk (pain) Toda (pricking sensation) Spandana ( pulsating or throbbing sensation) Stamba ( stiffness)Timepoint: 1.5 years

Countries

India

Contacts

Public ContactDr Harshitha N Y

Alvas Ayurveda Medical College and Hospital

vikramkumar83@gmail.com9483141326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026